Oseaspre Consultants stake sale: 73.52% deal in 2026
Ask Iris
What the company disclosed and why it matters
Oseaspre Consultants Limited has disclosed a change-of-control transaction after its promoter group entered into a share purchase agreement (SPA) to sell a controlling stake to Nimesh Sahadeo Singh. The agreed transfer is for 1,47,043 fully paid-up equity shares, representing 73.52% of the company’s equity. The cash consideration mentioned for the SPA is ₹0.706 crore (₹70,58,064).
The company said it is not a party to the SPA, but it received a copy of the agreement on the date it was executed. The disclosure was made under Regulation 30 of the SEBI (LODR) Regulations, 2015. Alongside the stake sale process, Oseaspre Consultants’ board also approved a preferential issue and a related increase in authorised share capital, indicating that ownership and capital structure changes are moving in parallel.
SPA details: stake size, shares, and consideration
The SPA is dated September 18, 2026, and identifies Nimesh Sahadeo Singh as the sole acquirer. The sellers listed in the disclosure are Nowrosjee Wadia and Sons Limited, Tristar Charitable Foundation, Varnilam Investments and Trading Company Limited, Jehangir Nusli Wadia, and MSIL Investments Private Limited.
The promoters’ agreed transfer of 1,47,043 shares accounts for 73.52% of the company’s equity, as per the report. The consideration is entirely in cash at ₹0.706 crore. Since this is a controlling stake, it is paired with an open offer process for public shareholders.
Open offer: size, percentage, and the next disclosure date
Oseaspre Consultants has received an open offer from Nimesh Sahadeo Singh to acquire up to 1,82,000 fully paid-up equity shares. The company stated this represents 26.00% of the “emerging equity and voting share capital” of the company.
A key upcoming milestone is the publication of the Detailed Public Statement (DPS). The company indicated that the DPS, containing further details of the open offer, is expected to be published on or before September 25, 2026. This publication is a central part of the open offer timeline and is typically where shareholders look for additional process-related specifics.
Preferential issue approved on the same day
On September 18, 2026, the same date as the SPA execution, the board approved a preferential issue of up to 5,00,000 equity shares. The issue price is ₹48 per share, as disclosed.
The preferential issue requires shareholder approval. The company has scheduled an extraordinary general meeting (EGM) for October 30, 2026, to seek approvals. This sequencing matters for shareholders because the company is simultaneously navigating a control transfer and a potential equity issuance.
Authorised share capital to rise from ₹0.20 crore to ₹0.70 crore
Alongside the preferential issue, the company approved an increase in authorised share capital from ₹0.20 crore (₹20,00,000) to ₹0.70 crore (₹70,00,000). The disclosure also notes that this involves raising the number of equity shares from 2,00,000 to 7,00,000, with a face value of ₹10 per share.
An increase in authorised capital is typically a procedural step needed to enable a larger issuance of shares. In this case, it aligns with the preferential issue proposal disclosed by the company.
Key facts at a glance
Company profile and trading identifiers
Oseaspre Consultants Limited is an Indian public company established in 1982 and is primarily involved in providing technical know-how and related consultancy services. The company’s stock identifiers listed in the disclosure include BSE symbol 509782, NSE symbol OSEASPR, and ISIN INE880P01015. The group is shown as XT and the status as Active.
These identifiers become particularly relevant during corporate actions because investors track announcements and tendering-related updates through exchange filings.
Financial snapshot mentioned in the disclosure context
The article data also cites selected financial and market metrics for Oseaspre Consultants. For FY 2025, the company reported revenue of ₹0.218 crore (₹21.8 lakh), stated as up 342.00% year-on-year. It also notes that for fiscal year 2023-24, the company incurred a loss after tax of ₹0.143 crore (₹14.29 lakh), described as a higher loss compared to the previous year.
A quarterly snapshot shown for Jun ’26 lists revenue of ₹0.02 crore and a net profit/loss figure of -₹0.03 crore. Additional metrics listed include ROE of -8.60%, EPS (TTM) of -8.60, P/B ratio of 0.17, dividend yield of 484.68%, industry P/E of 43.46, and book value of 106.22.
Market impact: what changes shareholders will be tracking
The immediate market relevance of the disclosures is that a 73.52% promoter stake transfer signals a change in control and is accompanied by an open offer to public shareholders for up to 26.00% of the emerging equity and voting capital. Investors typically track the DPS date closely because it brings more detail on the open offer process.
In parallel, the preferential issue proposal can influence how investors assess the company’s future equity base, because it introduces the possibility of new shares being issued at ₹48 per share, subject to shareholder approval at the October 30, 2026 EGM. The increase in authorised share capital from ₹0.20 crore to ₹0.70 crore is also part of that capital-raising pathway.
Analysis: two corporate actions unfolding together
Two separate but related tracks are evident in the disclosures dated September 18, 2026. First is the SPA that shifts control to a named acquirer through a large block transfer for cash consideration. Second is a board-approved preferential issue proposal, with an enabling step to increase authorised capital.
For shareholders, the key is that the company has clearly stated it is not a party to the SPA, while still communicating that it has received a copy and is disclosing the development as required. The next confirmed milestones are the DPS publication on or before September 25, 2026 and the EGM on October 30, 2026 for approvals related to the preferential issue and authorised capital changes.
Conclusion
Oseaspre Consultants has disclosed a promoter stake sale that transfers 73.52% control to Nimesh Sahadeo Singh for ₹0.706 crore, alongside an open offer for up to 1,82,000 shares (26.00% of emerging equity and voting capital). Separately, the board has approved a preferential issue of up to 5,00,000 shares at ₹48 per share and an authorised capital increase from ₹0.20 crore to ₹0.70 crore.
The next scheduled checkpoints are the Detailed Public Statement expected by September 25, 2026 and the extraordinary general meeting on October 30, 2026 for shareholder approvals tied to the preferential issue and capital increase.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
